Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Short-term Investments: 2019-2025

Historic Short-term Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $488.0 million.

  • IDEAYA Biosciences' Short-term Investments fell 6.11% to $488.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.0 million, marking a year-over-year decrease of 6.11%. This contributed to the annual value of $591.9 million for FY2024, which is 60.81% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Short-term Investments stood at $488.0 million for Q3 2025, which was down 12.09% from $555.1 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Short-term Investments registered a high of $591.9 million during Q4 2024, and its lowest value of $154.7 million during Q4 2021.
  • Its 3-year average for Short-term Investments is $470.4 million, with a median of $518.6 million in 2024.
  • The largest annual percentage gain for IDEAYA Biosciences' Short-term Investments in the last 5 years was 703.41% (2021), contrasted with its biggest fall of 26.86% (2021).
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Short-term Investments stood at $154.7 million in 2021, then skyrocketed by 91.44% to $296.2 million in 2022, then grew by 24.27% to $368.1 million in 2023, then spiked by 60.81% to $591.9 million in 2024, then dropped by 6.11% to $488.0 million in 2025.
  • Its Short-term Investments stands at $488.0 million for Q3 2025, versus $555.1 million for Q2 2025 and $562.5 million for Q1 2025.